远端胰腺切除术后胰瘘的危险因素与减轻策略:国际多中心2026例分析
这项国际多中心回顾性研究分析了2026例远端胰腺切除术,发现临床相关胰瘘(CR-POPF)发生率为15.1%,独立危险因素包括年龄<60岁、肥胖、低白蛋白血症、无硬膜外麻醉、神经内分泌或非恶性肿瘤、合并脾切除和血管切除;多种胰腺残端处理技术和预防性奥曲肽未显示独立关联,术中引流与更高瘘率但更低瘘严重度相关。
要点
- CR-POPF发生率为15.1%,年龄<60岁、肥胖、低白蛋白血症等为独立危险因素。
- 合并脾切除和血管切除显著增加CR-POPF风险。
- 胰腺离断方式、缝合结扎、吻合器加固、生物密封剂和预防性奥曲肽均未显示独立关联。
核心结论
- CR-POPF发生率无法可靠预测,开发风险评分模型的机会有限。
研究设计与样本
- 国际多中心回顾性研究,纳入2001-2016年10个中心52位外科医生完成的2026例远端胰腺切除术。
主要发现
- 306例(15.1%)发生CR-POPF。
- 年龄<60岁(OR 1.42,95% CI 1.05-1.82)、肥胖(OR 1.54,95% CI 1.19-2.12)、低白蛋白血症(OR 1.63,95% CI 1.06-2.51)、无硬膜外麻醉(OR 1.59,95% CI 1.17-2.16)、神经内分泌或非恶性肿瘤(OR 1.56,95% CI 1.18-2.06)、合并脾切除(OR 1.99,95% CI 1.25-3.17)、血管切除(OR 2.29,95% CI 1.25-3.17)为独立危险因素。
- 术中引流与更高瘘率相关(OR 2.09,95% CI 1.51-3.78),但降低瘘严重度(P < 0.001)。
临床怎么用
- 对于存在年龄<60岁、肥胖、低白蛋白血症、无硬膜外麻醉、神经内分泌或非恶性肿瘤、合并脾切除或血管切除等高危因素的患者,应加强术后胰瘘监测。
- 胰腺离断方式、缝合结扎、吻合器加固、生物密封剂和预防性奥曲肽未显示独立降低CR-POPF风险,临床决策需结合具体情况。
局限性
- 回顾性研究设计可能存在选择偏倚和未测量混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To identify a clinical fistula risk score following distal pancreatectomy. BACKGROUND: Clinically relevant pancreatic fistula (CR-POPF) following distal pancreatectomy (DP) is a dominant contributor to procedural morbidity, yet risk factors attributable to CR-POPF and effective practices to reduce its occurrence remain elusive. METHODS: This multinational, retrospective study of 2026 DPs involved 52 surgeons at 10 institutions (2001-2016). CR-POPFs were defined by 2016 International Study Group criteria, and risk models generated using stepwise logistic regression analysis were evaluated by c-statistic. Mitigation strategies were assessed by regression modeling while controlling for identified risk factors and treating institution. RESULTS: CR-POPF occurred following 306 (15.1%) DPs. Risk factors independently associated with CR-POPF included: age (<60 yrs: OR 1.42, 95% CI 1.05-1.82), obesity (OR 1.54, 95% CI 1.19-2.12), hypoalbuminenia (OR 1.63, 95% CI 1.06-2.51), the absence of epidural anesthesia (OR 1.59, 95% CI 1.17-2.16), neuroendocrine or nonmalignant pathology (OR 1.56, 95% CI 1.18-2.06), concomitant splenectomy (OR 1.99, 95% CI 1.25-3.17), and vascular resection (OR 2.29, 95% CI 1.25-3.17). After adjusting for inherent risk between cases by multivariable regression, the following were not independently associated with CR-POPF: method of transection, suture ligation of the pancreatic duct, staple size, the use of staple line reinforcement, tissue patches, biologic sealants, or prophylactic octreotide. Intraoperative drainage was associated with a greater fistula rate (OR 2.09, 95% CI 1.51-3.78) but reduced fistula severity (P < 0.001). CONCLUSIONS: From this large analysis of pancreatic fistula following DP, CR-POPF occurrence cannot be reliably predicted. Opportunities for developing a risk score model are limited for performing risk-adjusted analyses of mitigation strategies and surgeon performance.
引用
- Ecker BL, McMillan MT, Allegrini V, et al. Risk Factors and Mitigation Strategies for Pancreatic Fistula After Distal Pancreatectomy: Analysis of 2026 Resections From the International, Multi-institutional Distal Pancreatectomy Study Group. Ann Surg. 2019. PMID: 28857813. doi:10.1097/SLA.0000000000002491
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。